Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound MEDLINE
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for Windows
(budesonide nasal )
562 results
  • Comparison of the Modified Version of DRAF III to the Conventional DRAF III: A 5 Year Study. [Journal Article]
    Indian J Otolaryngol Head Neck Surg 2019; 71(3):334-340Varghese G, Sahadevan A
  • A modification is made to the conventional way of doing Draf III by completely avoiding burrs by using only gouges and punches to reduce the postoperative narrowing followed by local instillation of budesonide solution. The results are compared. The comparison was made in terms of surgical duration, frontal ostium size, and recurrence of pathology. This is a prospective non-randomised comparative…
  • Omalizumab versus intranasal steroids in the post-operative management of patients with allergic fungal rhinosinusitis. [Journal Article]
    Eur Arch Otorhinolaryngol 2019Mostafa BE, Fadel M, … Askoura AM
  • CONCLUSIONS: We compared a single post operative injection of omalizumab with twice daily intranasal steroid spray for 6 months. Both treatments were effective, but the omalizumab group showed a more significant clinical and endoscopic response. There were no significant side effects in both arms. This novel approach used a single low dose injection of omalizumab increased the compliance of the patients with minimal complications. Longer follow-up of the patients is ongoing to determine the optimal time for re-injection. The only downside was the higher cost of omalizumab compared to that of local steroids.
New Search Next